PRIVIA HEALTH GROUP INC (PRVA) Fundamental Analysis & Valuation

NASDAQ:PRVA • US74276R1023

21.73 USD
-0.34 (-1.54%)
At close: Mar 12, 2026
21.73 USD
0 (0%)
Pre-Market: 3/13/2026, 4:59:34 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This PRVA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Taking everything into account, PRVA scores 5 out of 10 in our fundamental rating. PRVA was compared to 101 industry peers in the Health Care Providers & Services industry. While PRVA has a great health rating, its profitability is only average at the moment. PRVA shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

4

1. PRVA Profitability Analysis

1.1 Basic Checks

  • In the past year PRVA was profitable.
  • PRVA had a positive operating cash flow in the past year.
  • In multiple years PRVA reported negative net income over the last 5 years.
  • In the past 5 years PRVA always reported a positive cash flow from operatings.
PRVA Yearly Net Income VS EBIT VS OCF VS FCFPRVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M

1.2 Ratios

  • The Return On Assets of PRVA (1.67%) is comparable to the rest of the industry.
  • The Return On Equity of PRVA (3.11%) is comparable to the rest of the industry.
  • The Return On Invested Capital of PRVA (2.75%) is comparable to the rest of the industry.
  • PRVA had an Average Return On Invested Capital over the past 3 years of 2.17%. This is significantly below the industry average of 8.98%.
  • The 3 year average ROIC (2.17%) for PRVA is below the current ROIC(2.75%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.67%
ROE 3.11%
ROIC 2.75%
ROA(3y)1.75%
ROA(5y)-4.65%
ROE(3y)3.16%
ROE(5y)-7.26%
ROIC(3y)2.17%
ROIC(5y)N/A
PRVA Yearly ROA, ROE, ROICPRVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • The Profit Margin of PRVA (1.08%) is comparable to the rest of the industry.
  • PRVA's Profit Margin has declined in the last couple of years.
  • The Operating Margin of PRVA (1.61%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of PRVA has declined.
  • Looking at the Gross Margin, with a value of 9.87%, PRVA is doing worse than 75.25% of the companies in the same industry.
  • PRVA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.61%
PM (TTM) 1.08%
GM 9.87%
OM growth 3YN/A
OM growth 5Y-12.3%
PM growth 3YN/A
PM growth 5Y-22.33%
GM growth 3Y-0.24%
GM growth 5Y-0.49%
PRVA Yearly Profit, Operating, Gross MarginsPRVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. PRVA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PRVA is destroying value.
  • PRVA has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for PRVA has been increased compared to 5 years ago.
  • There is no outstanding debt for PRVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PRVA Yearly Shares OutstandingPRVA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
PRVA Yearly Total Debt VS Total AssetsPRVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 4.32 indicates that PRVA is not in any danger for bankruptcy at the moment.
  • PRVA has a better Altman-Z score (4.32) than 81.19% of its industry peers.
  • PRVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.32
ROIC/WACC0.31
WACC8.85%
PRVA Yearly LT Debt VS Equity VS FCFPRVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 1.60 indicates that PRVA should not have too much problems paying its short term obligations.
  • The Current ratio of PRVA (1.60) is better than 63.37% of its industry peers.
  • A Quick Ratio of 1.60 indicates that PRVA should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.60, PRVA is doing good in the industry, outperforming 65.35% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 1.6
PRVA Yearly Current Assets VS Current LiabilitesPRVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. PRVA Growth Analysis

3.1 Past

  • PRVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.55%, which is quite impressive.
  • The Earnings Per Share has been decreasing by -9.93% on average over the past years.
  • PRVA shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.26%.
  • The Revenue has been growing by 21.04% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)54.55%
EPS 3Y9.35%
EPS 5Y-9.93%
EPS Q2Q%133.33%
Revenue 1Y (TTM)22.26%
Revenue growth 3Y16.09%
Revenue growth 5Y21.04%
Sales Q2Q%-31.71%

3.2 Future

  • The Earnings Per Share is expected to grow by 57.20% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, PRVA will show a quite strong growth in Revenue. The Revenue will grow by 10.44% on average per year.
EPS Next Y106.06%
EPS Next 2Y65.53%
EPS Next 3Y57.2%
EPS Next 5YN/A
Revenue Next Year16.36%
Revenue Next 2Y11.95%
Revenue Next 3Y12.41%
Revenue Next 5Y10.44%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PRVA Yearly Revenue VS EstimatesPRVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
PRVA Yearly EPS VS EstimatesPRVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. PRVA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 127.82, which means the current valuation is very expensive for PRVA.
  • PRVA's Price/Earnings is on the same level as the industry average.
  • The average S&P500 Price/Earnings ratio is at 25.71. PRVA is valued rather expensively when compared to this.
  • With a Price/Forward Earnings ratio of 62.03, PRVA can be considered very expensive at the moment.
  • PRVA's Price/Forward Earnings ratio is in line with the industry average.
  • When comparing the Price/Forward Earnings ratio of PRVA to the average of the S&P500 Index (23.82), we can say PRVA is valued expensively.
Industry RankSector Rank
PE 127.82
Fwd PE 62.03
PRVA Price Earnings VS Forward Price EarningsPRVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • 62.38% of the companies in the same industry are cheaper than PRVA, based on the Enterprise Value to EBITDA ratio.
  • 70.30% of the companies in the same industry are more expensive than PRVA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.45
EV/EBITDA 50.02
PRVA Per share dataPRVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • PRVA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as PRVA's earnings are expected to grow with 57.20% in the coming years.
PEG (NY)1.21
PEG (5Y)N/A
EPS Next 2Y65.53%
EPS Next 3Y57.2%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PRVA Dividend Analysis

5.1 Amount

  • No dividends for PRVA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PRVA Fundamentals: All Metrics, Ratios and Statistics

PRIVIA HEALTH GROUP INC

NASDAQ:PRVA (3/12/2026, 8:05:46 PM)

Premarket: 21.73 0 (0%)

21.73

-0.34 (-1.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners99.61%
Inst Owner Change0.49%
Ins Owners1.85%
Ins Owner Change7.46%
Market Cap2.69B
Revenue(TTM)2.12B
Net Income(TTM)22.92M
Analysts84.29
Price Target32.15 (47.95%)
Short Float %2.3%
Short Ratio3.41
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)43.55%
Min EPS beat(2)-8.97%
Max EPS beat(2)96.08%
EPS beat(4)1
Avg EPS beat(4)-2.92%
Min EPS beat(4)-60.96%
Max EPS beat(4)96.08%
EPS beat(8)1
Avg EPS beat(8)-23.29%
EPS beat(12)3
Avg EPS beat(12)-1.19%
EPS beat(16)6
Avg EPS beat(16)61.33%
Revenue beat(2)1
Avg Revenue beat(2)5.86%
Min Revenue beat(2)-6.18%
Max Revenue beat(2)17.91%
Revenue beat(4)3
Avg Revenue beat(4)4.55%
Min Revenue beat(4)-6.18%
Max Revenue beat(4)17.91%
Revenue beat(8)7
Avg Revenue beat(8)4.33%
Revenue beat(12)10
Avg Revenue beat(12)3.07%
Revenue beat(16)10
Avg Revenue beat(16)-7.25%
PT rev (1m)0%
PT rev (3m)0.39%
EPS NQ rev (1m)8.36%
EPS NQ rev (3m)3.76%
EPS NY rev (1m)8.83%
EPS NY rev (3m)8.58%
Revenue NQ rev (1m)-2.19%
Revenue NQ rev (3m)-28.24%
Revenue NY rev (1m)2.51%
Revenue NY rev (3m)-35.7%
Valuation
Industry RankSector Rank
PE 127.82
Fwd PE 62.03
P/S 1.27
P/FCF 16.45
P/OCF 16.45
P/B 3.65
P/tB 8.63
EV/EBITDA 50.02
EPS(TTM)0.17
EY0.78%
EPS(NY)0.35
Fwd EY1.61%
FCF(TTM)1.32
FCFY6.08%
OCF(TTM)1.32
OCFY6.08%
SpS17.16
BVpS5.96
TBVpS2.52
PEG (NY)1.21
PEG (5Y)N/A
Graham Number4.77
Profitability
Industry RankSector Rank
ROA 1.67%
ROE 3.11%
ROCE 4.27%
ROIC 2.75%
ROICexc 6.87%
ROICexgc N/A
OM 1.61%
PM (TTM) 1.08%
GM 9.87%
FCFM 7.7%
ROA(3y)1.75%
ROA(5y)-4.65%
ROE(3y)3.16%
ROE(5y)-7.26%
ROIC(3y)2.17%
ROIC(5y)N/A
ROICexc(3y)6.14%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.37%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y-16.37%
OM growth 3YN/A
OM growth 5Y-12.3%
PM growth 3YN/A
PM growth 5Y-22.33%
GM growth 3Y-0.24%
GM growth 5Y-0.49%
F-Score6
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 136.39
Cash Conversion 370.18%
Profit Quality 712.96%
Current Ratio 1.6
Quick Ratio 1.6
Altman-Z 4.32
F-Score6
WACC8.85%
ROIC/WACC0.31
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)607.4%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.55%
EPS 3Y9.35%
EPS 5Y-9.93%
EPS Q2Q%133.33%
EPS Next Y106.06%
EPS Next 2Y65.53%
EPS Next 3Y57.2%
EPS Next 5YN/A
Revenue 1Y (TTM)22.26%
Revenue growth 3Y16.09%
Revenue growth 5Y21.04%
Sales Q2Q%-31.71%
Revenue Next Year16.36%
Revenue Next 2Y11.95%
Revenue Next 3Y12.41%
Revenue Next 5Y10.44%
EBIT growth 1Y101.6%
EBIT growth 3YN/A
EBIT growth 5Y6.15%
EBIT Next Year470.08%
EBIT Next 3Y100.08%
EBIT Next 5Y56.77%
FCF growth 1Y49.53%
FCF growth 3Y51.38%
FCF growth 5Y33.52%
OCF growth 1Y49.53%
OCF growth 3Y51.28%
OCF growth 5Y33.26%

PRIVIA HEALTH GROUP INC / PRVA FAQ

What is the fundamental rating for PRVA stock?

ChartMill assigns a fundamental rating of 5 / 10 to PRVA.


Can you provide the valuation status for PRIVIA HEALTH GROUP INC?

ChartMill assigns a valuation rating of 3 / 10 to PRIVIA HEALTH GROUP INC (PRVA). This can be considered as Overvalued.


Can you provide the profitability details for PRIVIA HEALTH GROUP INC?

PRIVIA HEALTH GROUP INC (PRVA) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for PRVA stock?

The Price/Earnings (PE) ratio for PRIVIA HEALTH GROUP INC (PRVA) is 127.82 and the Price/Book (PB) ratio is 3.65.


Can you provide the financial health for PRVA stock?

The financial health rating of PRIVIA HEALTH GROUP INC (PRVA) is 7 / 10.